DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

Biogen Idec (NASDAQ: BIIB)

305.40 -1.34 (-0.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $305.40 -0.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $307.00
Previous Close $306.74
Daily Range $302.45 - $307.64
52-Week Range $270.27 - $358.89
Market Cap $72.1B
P/E Ratio 29.05
Dividend (Yield) $0.00 (0.0%)
Volume 1,932,231
Average Daily Volume 1,677,621
Current FY EPS $13.42

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

This High-Yield Dividend Stock Screams Danger

This high-yield dividend stock may be paying out north of 7%, but its long-term outlook might have investors wisely running in the opposite direction.

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog

FDA Orders New Label For Biogen Idec's MS Drug

Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog

Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog

Ocera Therapeutics (OCRX) Worth Watching: Stock Up 9.4% - Tale of the Tape

SPY, BA, COP, BIIB: ETF Outflow Alert

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog

3 Stocks Reiterated As A Buy: MU, NTAP, BIIB

5 Health Care Stocks That Need to Play Serious Catch Up

See More BIIB News...

BIIB's Top Competitors

BIIB $305.40 (-0.44%)
Current stock: BIIB
AMGN $162.24 (-1.18%)
Current stock: AMGN
GILD $101.11 (0.51%)
Current stock: GILD
$0.00 (0.00%)
Current stock: